Evidence Synthesis Series – Webinar 2
Since 2021, more than 20 states have passed legislation requiring the coverage of biomarker testing by state-regulated insurers – typically including both commercial plans and state Medicaid agencies. This presentation explores the impetus for this recent trend and uses a 50-state review to explain the structure of these laws and their potential impact on Medicaid […]